The Executive Group of the #COVID19 Solidarity Trial met on Saturday to review a study on hydroxychloroquine and decided to temporarily pause this arm of the trial while data is reviewed. https://bit.ly/2LYa4rG 

The review will consider data collected so far in the Solidarity and other trials, in particular robust randomised data, to evaluate the potential benefits and harms from the use of hydroxychloroquine. The other arms of the Solidarity trial are continuing. #COVID19

I wish to reiterate that hydroxychloroquine and chloroquine are accepted as generally safe for use in patients with autoimmune diseases or malaria.

WHO will provide further updates as we know more. #COVID19